Dr. Indusekhara Subbanna
Qualification: MBBS, MD (Radiation Oncology), Diploma (Radiation Medicine), Diploma (Medical Law and Ethics)
Specialities: Radiation Oncology
Locations: HCG Cancer Center – KR BLR
Introduction
Dr. Indusekhara Subbanna is an accomplished Consultant Radiologist and the Head of the Department (HOD) at Healthcare Global Speciality Hospital, Bangalore. With an extensive career spanning over three decades, he is recognized for his expertise in diagnostic radiology, interventional radiology, and advanced medical imaging techniques. Dr. Subbanna has made significant contributions to the field through research and academic guidance, mentoring numerous postgraduates and fellows in radiology.
Area of Expertise
Dr. Subbanna specializes in the following areas:
- Interventional Radiology: Utilizing minimally invasive procedures for diagnosis and treatment, particularly in complex biliary pathologies and vascular interventions.
- Radiology: Advanced imaging techniques, including CT, MRI, and ultrasound, for comprehensive diagnostic solutions.
- Oncology Radiology: Expertise in liver cancers, hepatocellular carcinoma, and the management of biliary strictures.
Academic Qualification
- MBBS from the University of Mysore (1976), recognized by the Karnataka Medical Council.
- MD in Radiodiagnosisfrom the University of Bombay (1985), also registered with the Karnataka Medical Council.
Professional Experience
Dr. Subbanna’s distinguished career includes prestigious roles in leading hospitals:
- Consultant Radiologist & HOD at Healthcare Global Speciality Hospital, Bangalore (since August 2008).
- Senior Specialist & HOD at New Sohar Hospital, Oman (1998-2003).
- Professor & HOD at M S Ramaiah Teaching Hospital, Bangalore (1997-1998).
- Postdoctoral Fellow at Institut Gustave Roussy, Villejuif, France (1990-1992).
Research & Publications
Dr. Subbanna has made significant contributions to the scientific community through research, particularly in the fields of interventional radiology and complex biliary diseases. Notable publications include:
- “Experimental study of Balloon Expandable Metallic stents in Rabbit Vena Cava” in Journal of Cardiovascular and Interventional Radiology (1993).
- “Portal Vein Embolisation for inducing left Hepatic lobe hypertrophy before surgery” in Radiology (1993).
- “Percutaneous Treatment of Complex Biliary Stenosis using Gianturco Metallic Stents” (1991).
His research has also been presented at prominent conferences, including:
- 49th IR & IA Conference in Bangalore.
- ISVIR Conference in Delhi.
Medical Breakthroughs
Dr. Subbanna has made significant contributions to the scientific community through research, particularly in the fields of interventional radiology and complex biliary diseases. Notable publications include:
- “Experimental study of Balloon Expandable Metallic stents in Rabbit Vena Cava” in Journal of Cardiovascular and Interventional Radiology (1993).
- “Portal Vein Embolisation for inducing left Hepatic lobe hypertrophy before surgery” in Radiology (1993).
- “Percutaneous Treatment of Complex Biliary Stenosis using Gianturco Metallic Stents” (1991).
His research has also been presented at prominent conferences, including:
- 49th IR & IA Conference in Bangalore.
- ISVIR Conference in Delhi.
Awards & Accolades
Dr. Subbanna has received recognition for his pioneering contributions to radiology and interventional procedures, including:
- Best Paper Awards at national conferences.
- Recognized Researcher in the field of interventional radiology.
- Mentorship Award for guiding fellows and postgraduates in the field of interventional radiology.
Thesis Guidance & Mentorship:
Dr. Subbanna has been an active thesis guide for numerous medical professionals, particularly in the field of interventional radiology. Some of his recent guided theses include:
- Dr. Ayush Khadelwal: Radiomics in Hepatocellular carcinoma: Identification of Markers for prediction of Initial Deb-TACE response (2023).
- Dr. Devanth Ravikanth: CT-Based Radiomic features for prediction of Deb-TACE response in HCC (2022).
- Dr. Gaurav Benjwal: Intra-Arterial Fibroblast Activation Protein Inhibition Therapy in Patients with Advanced Hepatocellular Carcinoma (2022).
- Dr. Neeraj Mehta: Intra-arterial Lutetium-177 FAPI Radionuclide Therapy for Liver Metastases: A Pilot Study (2023).